Journal Article Review Epublish
PubMed: 40519877 DOI: 10.1016/j.rpth.2025.102881
Identifying and addressing underuse in hematologic care through systems-based hematology.
Res Pract Thromb Haemost 9(4):102881
Authors: Jacob C Cogan, Allison E Burnett, Alexandra Power-Hays, Geoffrey D Barnes, Ming Y Lim
Affiliations
- Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
- College of Pharmacy, University of New Mexico Hospital, Albuquerque, New Mexico, USA.
- Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA.
- Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Abstract
Underuse of high-value hematologic care receives comparatively less attention than the overuse of unnecessary tests and treatments. In this review, we analyze examples of underutilized care in several domains: procedural (inferior vena cava filter retrieval), medical (hydroxyurea use in sickle cell anemia), and patient-facing (education prior to anticoagulation). For each, we justify the need for increased uptake and highlight examples of systems-based hematology interventions to accomplish this. While reducing overused care is appealing from a cost savings perspective, we advocate for equal attention and investment toward promoting underused care.
MeSH
Vena Cava Filters, Hematology, Anemia, Sickle Cell, Hydroxyurea